ATXS

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Astria Therapeutics (ATXS) Earnings Date & Reports

Industry: @Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

ATXS is expected to report earnings to rise 7.62% to -45 cents per share on March 06

Astria Therapeutics ATXS Stock Earnings Reports

Q4'24

Est.

$-0.45

Q3'24

Est.

$-0.42

Q2'24

Missed

by $0.06

Q1'24

Missed

by $0.03

Q4'23

Missed

by $0.08

The last earnings report on November 13 showed earnings per share of -41 cents, meeting the estimate of -41 cents. With 108.40K shares outstanding, the current market capitalization sits at 437.37M.

View a ticker or compare two or three

Compare

ATXS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For ATXS
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for ATXS (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a developer of new medicines for the treatment of cardiovascular, metabolic and inflammatory diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

75 State Street

Phone

+1 617 349-1971

Employees

Web

https://www.astriatx.com